Personal profile
Fingerprint
Dive into the research topics where Tal Brosh Nissimov is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Quantitative association of blood culture volume with contaminant and pathogen recovery
Cahan, A., Sorek, N. & Brosh-Nissimov, T., 1 Mar 2026, In: Infectious Medicine. 5, 1, 100241.Research output: Contribution to journal › Article › peer-review
Open Access -
The effect of intrauterine exposure to aminoglycosides on neonatal hearing
Leshin-Carmel, D., Kariv, L., Mor, N., Neeman, O., Tirosh, N. B. & Brosh-Nissimov, T., 1 Feb 2026, In: Journal of Antimicrobial Chemotherapy. 81, 2, dkaf483.Research output: Contribution to journal › Article › peer-review
-
Aminoglycoside versus β-lactam treatment for urosepsis - A retrospective cohort study
Cahan, A., Peleg, R., Sorek, N. & Brosh-Nissimov, T., 1 Aug 2025, In: JAC-Antimicrobial Resistance. 7, 4, dlaf126.Research output: Contribution to journal › Article › peer-review
Open Access -
Effect of host-protein test (TRAIL/IP-10/CRP) on antibiotic prescription and emergency department or urgent care center return visits: The JUNO pilot randomized controlled trial
Singer, A. J., Hollander, J. E., Kean, E. R., Ring, H., Peacock, W. F., Soto-Ruiz, K. M., Motov, S., Thoppil, J., Hendry, P., Halabi, S., Meltzer, A. C., Headden, G. F., Brosh-Nissimov, T., Zeltser, D. & Cannon, C. M., 1 Sep 2025, In: Academic Emergency Medicine. 32, 9, p. 975-984 10 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Evaluation of sample pooling using Xpert Carba-R and Xpert vanA/vanB PCR for screening of carbapenemase-producing Enterobacterales and vancomycin-resistant Enterococcus colonization
Keidar-Friedman, D., Gil, L., Tsur, A., Brosh-Nissimov, T., Carmeli, Y., Rosenfeld, B. D. & Sorek, N., 7 Oct 2025, In: Microbiology Spectrum. 13, 10Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Immunobridging Trials: An Important Tool to Protect Vulnerable and Immunocompromised Patients Against Evolving Pathogens
on behalf of the Global Immunocompromised Health Coalition, 1 Jan 2025, In: Vaccines. 13, 1, 19.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Infection with COVID-19 does not increase blood pressure in patients with chronic kidney disease
Angel-Korman, A., Mayer, O., Brosh-Nissimov, T. & Leiba, A., 1 Nov 2025, In: Journal of Human Hypertension. 39, 11, p. 777-783 7 p.Research output: Contribution to journal › Article › peer-review
-
Invasive Mould Infections Following Combat-Related Injuries—A Retrospective Cohort Study
Hoffman, T., Haviv, Y., Cohen, A., Nesher, L., Schlaeffer-Yosef, T., Azulay, H., Brosh-Nissimov, T., Amit, S., Gazit, Z., Tribble, D. R., Ben-Ami, R. & Yahav, D., 1 Feb 2025, In: Mycoses. 68, 2, e70028.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Population-Based Study of Emergence and Spread of Escherichia coli Producing OXA-48-Like Carbapenemases, Israel, 2007-2023
CPE Working Group, 1 Jan 2025, In: Emerging Infectious Diseases. 31, 1, p. 66-74 9 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study
on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV), 1 Jan 2025, In: Infectious Diseases and Therapy. 14, 1, p. 167-180 14 p., e068632.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations